ALLOX closes $10.5M seed financing and appoints Morten Graugaard as Chair of Board of Dire... 02/11/2026 Healthcare Drug discovery Financing The biotech company ALLOX, located at the University of Barcelona Science Park (PCB-UB), developing a high-throughput... Partners - Parc Científic de Barcelona
ALLOX closes $10.5M seed financing and appoints Morten Graugaard as Chair to scale alloste... 30/10/2026 Healthcare Drug discovery Financing Financing led by Asabys, with participation from CDTI with its SICC Innvierte and the Institut Català de Finances (ICF). Partners - Asabys Partners
Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical ... 27/10/2026 Healthcare Drug discovery Innovative drugs Publication in this premier journal after rigorous peer review validates the VIRAGE study and supports the continued... Partners - THERIVA BIOLOGICS S.L.
IDP Pharma begins clinical trial for its drug IDP-121 in patients with small-cell lung c... 20/10/2026 Healthcare Drug discovery Innovative drugs The company IDP Pharma has initiated a Phase 1b/2 clinical trial for its drug candidate IDP-121, combining its use with... Partners - Parc Científic de Barcelona
Biomarkers and artificial intelligence open new avenues for anticipating Alzheimer’s progr... 21/09/2026 Healthcare Drug discovery Personalized medicine In Spain, nearly one million people were living with dementia in 2025, according to estimates from Alzheimer Europe... Partners - ADmit Therapeutics
Viva in Vitro and Vall d’Hebron will investigate the potential of functional NLRP3 biomark... 07/09/2026 Healthcare Drug discovery Personalized medicine The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of... Partners - VIVA IN VITRO
Madrid Science Park organizes Madrid Connect 2026 03/09/2026 Access to innovation Drug discovery Industrial biotechnology New Drug Discovery and Biomaterials, two of the event's three main pillars. The gathering offers debates, workshops, and... Partners - Fundación Parque Científico de Madrid
ORYZON announces Notice of Allowance for U.S. patent application covering iadademstat com... 31/08/2026 Healthcare Drug discovery Innovative drugs Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination with gilteritinib in... Partners - Oryzon Genomics
Neural Omega to present its full molecular mimicry pipeline at BioSpain 2026 31/08/2026 Healthcare Access to innovation Drug discovery From clinical data to drug discovery: Madrid-based biotech Neural Omega will make its international debut at BioSpain... Partners - NEURAL OMEGA
Celtarys Research expands into Targeted Protein Degradation with new tools for PROTAC and ... 28/08/2026 Healthcare Drug discovery Innovative drugs Celtarys Research has expanded its drug discovery portfolio into Targeted Protein Degradation (TPD), launching new... Partners - Celtarys Research
